News Releases

Date Title and Summary View
Jun 30, 2020
Jun 26, 2020
Jun 15, 2020
Jun 13, 2020
Jun 10, 2020
Jun 10, 2020
Jun 04, 2020
Johnson & Johnson to Host Annual Health for Humanity Investor Webcast
Health for Humanity Webcast to Highlight Company's Commitment to Lead and Meet Urgent Health Challenges Worldwide   Live Investor Webcast Scheduled for June 18, 2020 at 8:00 a.m. ET NEW BRUNSWICK, N.J. , June 4, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ), the world's largest and most
Jun 04, 2020
May 27, 2020
U.S. FDA Approves New Pediatric Formulation of SIRTURO® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020  — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO Ò (bedaquiline). SIRTURO ® is now indicated for use as part of combination
May 18, 2020
Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data to be Presented at the American Society of Clinical Oncology and the Janssen Oncology Strategy and Portfolio
NEW BRUNSWICK, N.J. , May 18, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) will participate in a pre-recorded fireside chat webcast hosted by Cantor Fitzgerald focused on clinical data being presented at the virtual 2020 American Society of Clinical
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.